WAVE Life Sciences Ltd (WVE)
6.26
+0.36
(+6.10%)
USD |
NASDAQ |
May 17, 16:00
6.26
0.00 (0.00%)
After-Hours: 20:00
WAVE Life Sciences Shareholders Equity (Quarterly): 25.39M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 25.39M |
| December 31, 2023 | 39.63M |
| September 30, 2023 | -40.49M |
| June 30, 2023 | -51.72M |
| March 31, 2023 | -34.71M |
| December 31, 2022 | -45.09M |
| September 30, 2022 | -4.519M |
| June 30, 2022 | 30.95M |
| March 31, 2022 | -0.053M |
| December 31, 2021 | 32.50M |
| September 30, 2021 | 29.90M |
| June 30, 2021 | 21.84M |
| March 31, 2021 | 52.82M |
| December 31, 2020 | 82.78M |
| September 30, 2020 | 108.24M |
| June 30, 2020 | -4.489M |
| March 31, 2020 | 20.86M |
| December 31, 2019 | 63.73M |
| September 30, 2019 | 114.77M |
| Date | Value |
|---|---|
| June 30, 2019 | 160.22M |
| March 31, 2019 | 196.86M |
| December 31, 2018 | 73.35M |
| September 30, 2018 | 106.61M |
| June 30, 2018 | 139.30M |
| March 31, 2018 | 110.05M |
| December 31, 2017 | 139.61M |
| September 30, 2017 | 165.86M |
| June 30, 2017 | 188.91M |
| March 31, 2017 | 117.09M |
| December 31, 2016 | 134.86M |
| September 30, 2016 | 151.13M |
| June 30, 2016 | 166.28M |
| March 31, 2016 | 146.52M |
| December 31, 2015 | 153.49M |
| September 30, 2015 | -3.12M |
| June 30, 2015 | 8.963M |
| December 31, 2014 | 2.027M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-51.72M
Minimum
Jun 2023
160.22M
Maximum
Jun 2019
30.13M
Average
27.64M
Median
Shareholders Equity (Quarterly) Benchmarks
| Haw Par Corp Ltd | 2.632B |
| ASLAN Pharmaceuticals Ltd | -17.96M |
| EUDA Health Holdings Ltd | -5.990M |
| CytoMed Therapeutics Ltd | 8.514M |
| Mobile-health Network Solutions | -0.3672M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 235.27M |
| Total Liabilities (Quarterly) | 209.88M |
| Current Ratio | 1.186 |